Recent progress of acute lymphoblastic leukemia: reports from the 19th European Hematology Association annual congress

VernacularTitle:急性淋巴细胞白血病临床研究进展:第19届欧洲血液学会年会报道
Author: Liangming MA
Publication Type:Journal Article
Keywords: Leukemia,lymphoblastic,acute; European Hematology Association annual congress
From: Journal of Leukemia & Lymphoma 2014;23(8):451-455
CountryChina
Language:Chinese
Abstract: Acute lymphoblastic leukemia (ALL) is a heterogeneous disease affected by many factors,including age,immunologic subtype,and clinical,genetic and molecular features,Improved tools can identify patients in remission based on morphology but those with active disease based on molecular biology or immunophenotype (minimal residual disease).B-cell antigen panels,clone-specific immunoglobulins,or T-cell receptor rearrangements is used to detect positivity at thresholds at least.There are 13 ALL clinical related abstracts (poster) in the 19th European Hematology Association annual congress which reflected recent progress of research ALL.